Coronary artery disease as a risk factor for metabolic dysfunction-associated steatotic liver disease and liver fibrosis

Introduction and Objectives: Patients with metabolic dysfunction-associated steatotic liver disease (MASLD) are at an increased cardiovascular risk. On the contrary, non-alcoholic fatty liver disease (NAFLD) is highly prevalent in patients with coronary heart disease (CHD). However, it is not known...

全面介紹

書目詳細資料

Principais autores:	Luis Vega, Daniela Simian, Abraham I. Gajardo, Marcelo Salinas, Andrea Urra, Máximo Cattaneo, Rosario Pino, Juan P. Roblero, Álvaro Urzúa, Katherine Rojas, Jaime Poniachik
格式:	Artigo
語言:	Inglês
出版:	Elsevier 2024-07-01
叢編:	Annals of Hepatology
主題:	Metabolic dysfunction-associated fatty liver disease Liver fibrosis Coronary heart disease
在線閱讀:	http://www.sciencedirect.com/science/article/pii/S1665268124003053
標簽:	添加標簽 沒有標簽, 成為第一個標記此記錄!